Oxford Biomedica plc
Oxford, United Kingdom
|
Oxford BioMedica plc is a biopharmaceutical company develops gene-based medicines and therapeutic vaccines that aim to improve the lives of patients with high unmet medical needs. The company's technology platforms include LentiVector® gene delivery system, which has specific advantages for targeting diseases of the central nervous system and the eye; and a unique tumour antigen (5T4), which is an ideal target for anti-cancer therapy.